IND Regulatory Services

Creative Biolabs provides comprehensive IND regulatory consulting and submission services.

Introduction Featured Services Highlights FAQs Resources Related Sections

Introduction

IND-Related Regulatory Services Provided by Creative Biolabs. (Creative Biolabs Authorized)

IND regulatory services play a pivotal role in advancing drug candidates from drug discovery to clinical stages by ensuring compliance with global regulations. Creative Biolabs offers a full suite of services that simplify this complex pathway, supporting clients in navigating regulatory demands effectively and efficiently. To help your pre-clinical development be in compliance with global regulations and to help gain IND approval for your drug candidates, we offer a comprehensive series of IND regulatory services, including strategy consulting, medical writing and translation, pre-IND meeting, IND publishing and submission, post-IND maintenance.

Get Customized Services →

Comprehensive IND Submission Solutions

To guide our clients to gain a successful Investigational New Drug application (IND), our regulatory service team is dedicated to the whole drug development process including study design, document preparation, etc. Our end-to-end IND regulatory solutions aim to meet the requirements of clients' pre-IND and IND submissions to ensure compliance with a broad range of regulations and protocols issued by global health authorities.

Regulatory Strategy Consulting

Identifies regulatory hurdles early, minimizing delays and ensuring submission readiness.

Medical Writing and Translation

Provides high-quality dossier preparation, formatted for region-specific standards (eCTD/CTD).
Ensures consistent terminology and data precision across all documentation.

Pre-IND Meeting Preparation

Prepares detailed materials and facilitates discussions to clarify study design, data, and regulatory requirements.
Maximizes client feedback from authorities, allowing data adjustments before formal submission.

IND Publishing and Submission

Assembles all required documents and validates each for eCTD compliance, adhering to FDA's XML backbone.
Streamlines the submission process, reducing risks of incomplete or misformatted data.

Post-IND Maintenance

Provides protocol amendments, safety updates, and annual reporting, ensuring ongoing compliance.
Addresses any regulatory requests, maintaining seamless clinical trial progression.

Fig.1 IND Regulatory Service. (Creative Biolabs Original) Fig.1 End-to-end Solution of IND Regulatory Service.

Why Choose Us?

Creative Biolabs' IND regulatory services stand out for their precision, adaptability, and depth of support. Key highlights of these services include:

Comprehensive Document Preparation and Submission

Creative Biolabs manages the entire IND documentation process, ensuring submission readiness and minimizing the need for resubmissions.

Investigator's Brochure (IB) Preparation

By compiling detailed study protocols and investigator data, Creative Biolabs enhances the IB's comprehensiveness, which is essential for regulatory review.

Seamless eCTD Compliance

Expertise in eCTD formatting and XML specifications ensures all digital submissions adhere to regulatory standards.

Real-Time Regulatory Engagement

Creative Biolabs supports clients in both pre-IND and IND meetings with the FDA, enhancing submission success rates by facilitating clear communication and addressing any regulatory concerns promptly.

Please contact us for a detailed communication about your requirements. An integrated end-to-end solution is recommended to ensure no gaps between each step, and individual module is also welcomed. Creative Biolabs is committed to serving our clients always the best.

FAQs

How does Creative Biolabs ensure document quality for eCTD submissions?

All submissions undergo a rigorous review process, with eCTD compliance checked at each stage to meet the technical and formatting standards specified by regulatory authorities.

What differentiates Creative Biolabs' approach to IND strategy consulting?

Creative Biolabs offers tailored consulting that addresses specific regulatory challenges based on the unique profile of each drug candidate, optimizing submission strategies and reducing approval timelines.

Can Creative Biolabs support IND submissions for both large molecules and small molecules?

Yes, Creative Biolabs has extensive experience with managing IND submissions for both large molecules (biologics) and small molecules. We tailor our submission approach to the requirements for biologics, including in-depth information on cell lines, purification steps, and stability testing. When it comes to small molecules, we're interested in the essential issues of chemical stability, toxicology, and pharmacokinetics. This combination allows us to provide tailored regulatory solutions based on the molecular properties and compliance requirements of each drug type to enhance the likelihood of a successful submission.